Comparison Chart Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 17:32:32 20/01/2026 GMT			5-day change	1st Jan Change
0.2960 ^USD	-3.27%		-4.84%	-14.69%

12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI
12-02	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	VIRAX BIOLABS GROUP LIMITED	Other Biotechnology & Medical Research	-3.59%	-4.84%	-14.69%	-85.89%	-	2.27M